Ingredients and output form: Betahistine Dihydrochloride 24.00 mg №30 tablets
Betahistine is approved for the treatment of Ménière’s disease and vestibular vertigo in more than 80 countries worldwide and has been reportedly prescribed more than 130 million patients.
Pharmacological Group: anti-vertigo medication
Read the instructions in detail before use.
From the drugstore is issued with form III recipe
Manufacturer: Eurofarma, Brasil